Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1619 1621
This examiner grants 46% of resolved cases
Thurman Michael Wheeler is a patent examiner assigned to Art Unit 1619 within Tech Center 1600. The examiner's professional record includes 625 resolved cases. The data indicates an allowance rate of 45.8% for these applications. This figure serves as a primary indicator of the probability of success for cases on this docket. Additionally, the median days to allowance is 1412, which establishes a specific timeframe for the prosecution process. These metrics offer a foundational understanding of the examiner's approach to patent applications.
The interview lift for this examiner is 23.5%. This 23.5% lift shows the change in the likelihood of allowance when an interview is conducted compared to the 45.8% base rate. With 625 resolved cases, the data provides a view of the examiner's historical performance. The 1412-day median pendency is a key metric for managing client expectations regarding the duration of the patent application process in Tech Center 1600. Practitioners should evaluate the allowance rate and the interview lift to determine the most effective strategy for their specific cases.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17821371 | Functionalized Mesoporous Silica via an Aminosilane Surfactant Ion Exchange Reaction: Controlled Scaffold Design and Nitric Oxide Release | Final Rejection | The University of North Carolina at Chapel Hill |
| 17800494 | DEVICE AND METHODS FOR ENGINEERING 3D COMPLEX TISSUES | Final Rejection | University of Washington |
| 16623591 | COSMETIC COMPOSITION COMPRISING TWO SPECIFIC CATIONIC SURFACTANTS AND A SILICONE EMULSION, AND A COSMETIC TREATMENT PROCESS | Non-Final OA | L'OREAL |
| 17370101 | DECELLULARIZATION OF TISSUES USING SUPERCRITICAL CARBON DIOXIDE | Non-Final OA | UNIVERSITY OF SOUTH CAROLINA |
| 17672894 | Microemulsion Delivery Systems for Alcohol-Soluble Species Including Nonderivatized Hormones | Final Rejection | Quicksilver Scientific, Inc. |
| 18309894 | ANTIMICROBIAL COMPOSITIONS | Non-Final OA | TAKASAGO INTERNATIONAL CORPORATION |
| 18433538 | METHODS OF CANCER TREATMENT VIA REGULATED FERROPTOSIS | Non-Final OA | Cornell University |
| 17053409 | BIOSCAFFOLD COMPOSITIONS OF MATTER | Non-Final OA | Ethicon, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy